GEMCITABIN "EBEWE" 1 G

Country: Իսրայել

language: անգլերեն

source: Ministry of Health

active_ingredient:

GEMCITABINE AS HYDROCHLORIDE 1000 MG

MAH:

PHARMALOGIC LTD

ATC_code:

L01BC05

pharmaceutical_form:

LYOPHILIZED POWDER FOR INJECTION

administration_route:

I.V

manufactured_by:

EBEWE PHARMA GES.M.B.H NFG. KG, AUSTRIA

therapeutic_group:

GEMCITABINE

therapeutic_indication:

Palliative treatment of patients with locally advanced or metastatic non-small cell lung cancer and locally advanced or metastatic adenocarcinoma of the pancreas and for patients with 5-FU refractory pancreatic cancer. Gemcitabine is indicated for the treatment of patients with bladder cancer at the invasive stage. Breast cancer: Gemcitabine in combination with paclitaxel is indicated for the treatment of patients with unresectable locally recurrent or metastatic breast cancer who have relapsed following adjuvant/neoadjuvant chemotherapy. Prior chemotherapy should have included an anthracycline unless clinically contraindicated. Ovarian cancer: Gemcitabine in combination with carboplatin is indicated for the treatment of patients with recurrent epithelial ovarian carcinoma whom have relapsed at least six months after platinum - based therapy.

authorization_date:

2010-04-01